Long-term follow up of pediatric Philadelphia positive acute lymphoblastic leukemia treated with the EsPhALL2004 study: high white blood cell count at diagnosis is the strongest prognostic factor

Saved in:
Bibliographic Details
Published inHaematologica (Roma) Vol. 104; no. 1; pp. e13 - e16
Main Authors Biondi, Andrea, Cario, Gunnar, De Lorenzo, Paola, Castor, Anders, Conter, Valentino, Leoni, Veronica, Gandemer, Virginie, Pieters, Rob, Stary, Jan, Escherich, Gabriele, Campbell, Myriam, Attarbaschi, Andishe, Li, Chi-Kong, Vora, Ajay, Bradtke, Jutta, Saha, Vaskar, Valsecchi, Maria Grazia, Schrappe, Martin
Format Journal Article
LanguageEnglish
Published Italy Ferrata Storti Foundation 01.01.2019
Subjects
Adolescent
Child
Child, Preschool
Disease-Free Survival
Female
Follow-Up Studies
Humans
Imatinib Mesylate - administration & dosage
Infant
Leukocyte Count
Male
Online Only
Philadelphia Chromosome
Precursor Cell Lymphoblastic Leukemia-Lymphoma - diagnosis
Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy
Precursor Cell Lymphoblastic Leukemia-Lymphoma - mortality
Survival Rate
pre-tyrosine kinase inhibitors (TKIs)
acute lymphoblastic leukemia (ALL)
Philadelphia chromosome
Online AccessGet full text

Cover

More Information
Bibliography:SourceType-Other Sources-1
content type line 63
ObjectType-Feature-2
ObjectType-Correspondence-1
ObjectType-Article-3
the last two authors share the senior authorship
ISSN:0390-6078
1592-8721
DOI:10.3324/haematol.2018.199422